1. Home
  2. ARVN vs HRTG Comparison

ARVN vs HRTG Comparison

Compare ARVN & HRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARVN
  • HRTG
  • Stock Information
  • Founded
  • ARVN 2015
  • HRTG 2012
  • Country
  • ARVN United States
  • HRTG United States
  • Employees
  • ARVN 430
  • HRTG N/A
  • Industry
  • ARVN Biotechnology: Pharmaceutical Preparations
  • HRTG Property-Casualty Insurers
  • Sector
  • ARVN Health Care
  • HRTG Finance
  • Exchange
  • ARVN Nasdaq
  • HRTG Nasdaq
  • Market Cap
  • ARVN 676.2M
  • HRTG 771.1M
  • IPO Year
  • ARVN 2018
  • HRTG 2014
  • Fundamental
  • Price
  • ARVN $9.45
  • HRTG $24.23
  • Analyst Decision
  • ARVN Buy
  • HRTG Buy
  • Analyst Count
  • ARVN 23
  • HRTG 3
  • Target Price
  • ARVN $17.61
  • HRTG $31.50
  • AVG Volume (30 Days)
  • ARVN 2.6M
  • HRTG 517.4K
  • Earning Date
  • ARVN 11-04-2025
  • HRTG 11-05-2025
  • Dividend Yield
  • ARVN N/A
  • HRTG N/A
  • EPS Growth
  • ARVN N/A
  • HRTG 76.20
  • EPS
  • ARVN N/A
  • HRTG 3.47
  • Revenue
  • ARVN $372,800,000.00
  • HRTG $841,666,000.00
  • Revenue This Year
  • ARVN $1.01
  • HRTG $5.15
  • Revenue Next Year
  • ARVN N/A
  • HRTG $6.80
  • P/E Ratio
  • ARVN N/A
  • HRTG $7.02
  • Revenue Growth
  • ARVN 299.57
  • HRTG 9.57
  • 52 Week Low
  • ARVN $5.90
  • HRTG $9.71
  • 52 Week High
  • ARVN $29.61
  • HRTG $29.10
  • Technical
  • Relative Strength Index (RSI)
  • ARVN 57.54
  • HRTG 49.22
  • Support Level
  • ARVN $9.01
  • HRTG $22.55
  • Resistance Level
  • ARVN $9.55
  • HRTG $24.81
  • Average True Range (ATR)
  • ARVN 0.49
  • HRTG 1.17
  • MACD
  • ARVN -0.10
  • HRTG -0.17
  • Stochastic Oscillator
  • ARVN 44.37
  • HRTG 30.79

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

About HRTG Heritage Insurance Holdings Inc.

Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance in various states in the United States. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally. Company operates in Alabama, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Maryland, Massachusetts, Mississippi, New Jersey, New York, North Carolina, Rhode Island, South Carolina.

Share on Social Networks: